Read More

Orthopedic Devices Maker Treace Medical Concepts’ Gloomy Forecast Cast Concerns Over Long-Term Viability

Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.

TMCI

Read More

Equinor Pumps Millions Into Standard Lithium’s Sustainable Projects

Equinor ASA (NYSE:EQNR) ventures into the lithium market through a strategic $160 million partnership with Standard Lithium Ltd (NYSE:SLI), aiming to accelerate sustainable lithium projects in the Smackover Formation. Equinor secures a 45% ownership stake, pledging a $30 million initial payment and up to $130 million in contingent investments, bolstering Standard Lithium's financial outlook.

EQNR